Home

Phreesia, Inc. Common Stock (PHR)

28.46
-0.54 (-1.86%)

Phreesia Inc is a healthcare technology company that focuses on transforming the patient experience

It provides a software platform designed to streamline patient intake processes, enhance communication between patients and healthcare providers, and improve overall administrative efficiency within medical practices. By offering solutions such as patient surveys, appointment scheduling, and payment processing, Phreesia aims to optimize workflows, increase patient engagement, and ultimately contribute to better health outcomes. The company is committed to empowering both patients and providers through innovative technology that enhances the healthcare journey.

SummaryNewsPress ReleasesChartHistoricalFAQ
Breaking Down Phreesia: 9 Analysts Share Their Viewsbenzinga.com
Via Benzinga · January 29, 2025
Deep Dive Into Phreesia Stock: Analyst Perspectives (5 Ratings)benzinga.com
Via Benzinga · January 8, 2025
Here's Why Phreesia's Average Revenue Per Client Will Accelerate: Analystbenzinga.com
Analyst predicts Phreesia's revenue per client will accelerate, as company shifts focus to monetizing existing clients. Upgraded rating and PT raised.
Via Benzinga · January 8, 2025
Visa To Rally Over 20%? Here Are 10 Top Analyst Forecasts For Wednesdaybenzinga.com
Via Benzinga · December 11, 2024
Deep Dive Into Phreesia Stock: Analyst Perspectives (5 Ratings)benzinga.com
Via Benzinga · December 11, 2024
Phreesia Earnings Review: Q3 Summarybenzinga.com
Via Benzinga · December 9, 2024
A Look Ahead: Phreesia's Earnings Forecastbenzinga.com
Via Benzinga · December 6, 2024
The Latest Analyst Ratings For Phreesiabenzinga.com
Via Benzinga · September 27, 2024
A Glimpse Into The Expert Outlook On Phreesia Through 4 Analystsbenzinga.com
Via Benzinga · August 30, 2024
A Glimpse Into The Expert Outlook On Phreesia Through 6 Analystsbenzinga.com
Via Benzinga · July 1, 2024
Earnings Scheduled For December 9, 2024benzinga.com
Via Benzinga · December 9, 2024
Costco To Rally More Than 10%? Here Are 10 Top Analyst Forecasts For Thursdaybenzinga.com
Via Benzinga · July 11, 2024
10 Health Care Stocks With Whale Alerts In Today's Sessionbenzinga.com
Via Benzinga · June 3, 2024
Assessing Phreesia: Insights From 12 Financial Analystsbenzinga.com
Via Benzinga · May 31, 2024
PHR Stock Earnings: Phreesia Beats EPS, Beats Revenue for Q1 2025investorplace.com
PHR stock results show that Phreesia beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2025.
Via InvestorPlace · May 30, 2024
Analyst Expectations For Phreesia's Futurebenzinga.com
Via Benzinga · March 15, 2024
Recap: Phreesia Q4 Earningsbenzinga.com
Via Benzinga · March 14, 2024
Phreesia Earnings Previewbenzinga.com
Via Benzinga · March 13, 2024
Why SentinelOne Shares Are Trading Lower By 16%? Here Are Other Stocks Moving In Friday's Mid-Day Sessionbenzinga.com
Via Benzinga · May 31, 2024
PHR Stock Earnings: Phreesia Misses EPS, Beats Revenue for Q4 2024investorplace.com
PHR stock results show that Phreesia missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2024.
Via InvestorPlace · March 14, 2024
Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Sessionbenzinga.com
Shares of AeroVironment, Inc. (NASDAQAVAV) moved lower during Wednesday’s session following second-quarter results.
Via Benzinga · December 6, 2023
Earnings Scheduled For March 14, 2024benzinga.com
Companies Reporting Before The Bell • Pharming (NASDAQPHAR) is projected to report earnings for its fourth quarter.
Via Benzinga · March 14, 2024
Assessing Phreesia: Insights From 7 Financial Analystsbenzinga.com
Via Benzinga · February 26, 2024
Bull Of The Day: Phreesiatalkmarkets.com
The firm offers appointments, clinical support, integration, registration, patient activation, analytics and reports, revenue cycle, patient surveys, and privacy and security products.
Via Talk Markets · February 5, 2024
5 Analysts Have This To Say About Phreesiabenzinga.com
Via Benzinga · January 3, 2024